ProShare Advisors LLC Has $168.79 Million Stake in The Clorox Company (NYSE:CLX)

ProShare Advisors LLC lowered its holdings in shares of The Clorox Company (NYSE:CLX) by 0.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,236,836 shares of the company’s stock after selling 4,339 shares during the quarter. ProShare Advisors LLC owned 1.00% of Clorox worth $168,791,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Ensign Peak Advisors Inc lifted its stake in Clorox by 0.8% in the second quarter. Ensign Peak Advisors Inc now owns 109,280 shares of the company’s stock valued at $14,913,000 after buying an additional 826 shares in the last quarter. Westwood Holdings Group Inc. lifted its position in Clorox by 2.2% in the 2nd quarter. Westwood Holdings Group Inc. now owns 12,169 shares of the company’s stock valued at $1,661,000 after acquiring an additional 264 shares in the last quarter. Capstone Triton Financial Group LLC boosted its stake in Clorox by 5.3% in the 2nd quarter. Capstone Triton Financial Group LLC now owns 6,048 shares of the company’s stock worth $825,000 after purchasing an additional 303 shares during the period. Thrivent Financial for Lutherans increased its holdings in Clorox by 8.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 8,855 shares of the company’s stock worth $1,208,000 after purchasing an additional 709 shares in the last quarter. Finally, Sei Investments Co. raised its stake in shares of Clorox by 0.5% in the 2nd quarter. Sei Investments Co. now owns 92,305 shares of the company’s stock valued at $12,598,000 after purchasing an additional 468 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.51% of the stock is currently owned by corporate insiders.

Clorox Stock Performance

CLX opened at $163.33 on Friday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.09. The business has a 50 day moving average of $149.14 and a 200-day moving average of $143.73. The stock has a market cap of $20.28 billion, a price-to-earnings ratio of 84.63, a PEG ratio of 3.29 and a beta of 0.40.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. On average, equities research analysts expect that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.99%. Clorox’s payout ratio is currently 252.85%.

Analysts Set New Price Targets

CLX has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft upped their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price target on shares of Clorox in a research note on Friday, September 6th. Barclays boosted their price objective on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Finally, TD Cowen assumed coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Six analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $143.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.